Answers are grounded in this paper and cite their sources.
By engaging nonadherent patients to restart their DM or lipid medications during a face-to-face consult, the OPCS pharmacist was able to influence and improve medication adherence and clinical outcomes, particularly among patients with diabetes. A positive ROI was demonstrated.
No takes yet. Share an insight, caveat, or question.
Spence et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: